BioCentury

BioCentury

Built for the next generation of biotech leaders.

Analysis
Proprietary Analysis

Extend your intelligence using ours. No one dives deeper into dissecting the latest trends than BioCentury, allowing you to better position your company to capitalize on change.

Data
Data in Context

Find licensing and investment opportunities, uncover competitive threats and identify potential partners using our curated database.

Events
Expand Your Reach

Connect with your peers in our global community of C-Suite executives and investors. Our networking events give you unparalleled access to industry leaders who share your need for investments, partnerships and advice.

Workspace
A Personal Portal

Use this customizable workspace to filter our warehouse of business intelligence to meet your specific information needs.

BioCentury Supports Your Biotech Business Needs

Explore some of the ways we can help you.

Create a Market Map

Identify the companies, programs and investors in your defined market

Develop a nuanced understanding of your target sector with data and analysis

Understand trends and issues shaping the future of your target market

Identify Potential Partners

Create a refined target list of potential partners from full biopharma universe

Evaluate potential partners by exploring their pipelines, funding, deals and strategies

Prepare for meetings with both data and context

Track Your Competition

Identify translational science threats in relevant targets, diseases and technologies

Create alerts for product and strategic developments at competing companies

Monitor investments in your therapeutic and technology spaces

Value Your Program

Use Company Profiles to identify comparable programs across the industry

Review investing and partnering deals in your pipeline or program space

Understand where your program fits in the industry pipeline

Editors' Picks

Trusted by Industry Leaders Worldwide

President of R&D at Takeda
Andrew Plump, M.D., Ph.D.

“When it comes to timely, relevant discussion of complex industry issues, BioCentury provides fact-based, in-depth reporting and analysis, resisting sensationalism and often incorporating multiple perspectives. This allows us as readers to walk away informed, and in some cases, with actionable insights.”

Managing Partner at Lundbeckfonden
Christian Elling, Ph.D.

“The quality and depth of BioCentury's reporting and analysis sets them apart from their competitors. BioCentury provides the most intelligent coverage of the pharma and biotech industry.”

Chairman & CEO at Jazz Pharmaceuticals
Bruce C. Cozadd

“I’ve been a BioCentury reader for eons. I find other sources have good insights around individual companies or events, but few provide intelligent commentary that gives me a comprehensive sense for what’s happening in a broad area. BioCentury’s “context setting” is really value-added and what sets them apart.”

A Network of Global Professionals

Building sustainable value through new relationships.

November 16-19, 2021 | Shanghai & Digital
BioCentury-BayHelix China Healthcare Summit

Armed with unprecedented funds, Chinese biotechs and medtechs are racing across the Bridge to Innovation.

The 8th BioCentury-BayHelix China Healthcare Summit is a propitious time to showcase how the China story promises to have a lasting impact on the global biopharma industry.

May 17-18, 2022 | Milan, Italy
BioEquity Europe

BioCentury and EBD Group are pleased to announce that the 22nd Bio€quity Europe conference will be held in Milan, Italy May 17-18, 2022.

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Milan, plus take advantage of two bonus days of digital 1x1 meetings.